Outcomes Following Allogeneic Stem Cell Transplantation Using Non-sibling Family Donors.
Allogeneic
Family donor
Non-sibling
Outcome
Transplant
Journal
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
ISSN: 0971-4502
Titre abrégé: Indian J Hematol Blood Transfus
Pays: India
ID NLM: 9425818
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
26
02
2018
accepted:
16
07
2018
entrez:
5
3
2019
pubmed:
5
3
2019
medline:
5
3
2019
Statut:
ppublish
Résumé
For patients requiring allogeneic stem cell transplant, in the absence of a HLA-matched sibling, an extended donor search within the family may yield a suitable donor especially in societies with a high prevalence of consanguinity. We describe outcomes in transplants with non-sibling family donors, and compare outcomes with controls having a sibling donor transplant. Retrospective analysis of all matched related (non-sibling) donor transplants between 1995 and 2015. For comparison, appropriate age, sex and disease-matched patients were chosen from the sibling transplants (MSD) performed during the same time period (± 2 years). Comparison between the fully matched non-sibling donor cohort and age, sex and disease-matched sibling donor transplants showed a significant increase in complications in the family donor group (viral infections, acute GVHD and rejection). Event-free survival and overall survival were significantly lower in the non-sibling donor cohort, and HLA disparity (1-2 antigen) further worsened the adverse impact. Though there was a significantly lower event-free and overall survival at 3 years in the family donor cohort, this did not retain significance in the multivariate analysis. This data on allogeneic transplants using family donors showed higher complication rates and poorer outcomes. However in situations where financial constraints prevent access to matched unrelated donor sources, extended family searches may be fruitful in yielding a donor, and modifications in conditioning regimens and improvement in supportive care may help in improving the outcomes in family donor transplants.
Identifiants
pubmed: 30828147
doi: 10.1007/s12288-018-0988-z
pii: 988
pmc: PMC6369069
doi:
Types de publication
Journal Article
Langues
eng
Pagination
43-49Déclaration de conflit d'intérêts
This study was not funded and there are no conflicts of interest to disclose.All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Références
Bone Marrow Transplant. 2000 Apr;25(8):815-21
pubmed: 10808201
Blood. 2003 Aug 15;102(4):1541-7
pubmed: 12714500
Ann Hum Biol. 2004 Mar-Apr;31(2):263-9
pubmed: 15204368
Braz J Med Biol Res. 2006 Oct;39(10):1297-304
pubmed: 17053839
Clin Transplant. 2011 May-Jun;25(3):475-80
pubmed: 20636407
Bone Marrow Transplant. 2013 Mar;48(3):346-50
pubmed: 22863723
Natl Med J India. 2012 May-Jun;25(3):187
pubmed: 23019741
N Engl J Med. 2014 Jul 24;371(4):339-48
pubmed: 25054717
J Pediatr Hematol Oncol. 2015 Apr;37(3):e154-7
pubmed: 25333838
Bone Marrow Transplant. 2015 Apr;50(4):545-52
pubmed: 25621800
Pediatr Transplant. 2016 Feb;20(1):120-3
pubmed: 26493691
Bone Marrow Transplant. 1998 Apr;21 Suppl 2:S24-7
pubmed: 9630320